CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Parallel Bio
Parallel Bio

Parallel Bio

Parallel Bio uses human immune organoids and computational tools to support drug discovery and therapy testing.

Brisbane, CA, US🇺🇸
Founded
2021
Accelerator
Y Combinator logoY CombinatorS21
Overview
Analysis
Compare
Fundraising
Employees
News
Library

Parallel Bio develops human-based systems for drug discovery using immune organoids, biological assays, and computational tools. Its platform evaluates therapies across samples from diverse donors to study human responses before clinical testing. The company works with pharmaceutical partners and develops internal programs targeting cancer and autoimmune disease.

The company combines a patient-sample biobank with automated experiments to generate biological datasets. These data support disease-target discovery, therapy evaluation, and patient stratification. Parallel Bio positions this approach as an alternative to relying exclusively on animal models, with human biological diversity central to its experimental design.

Parallel Bio - Similar Companies

Rosebud Biosciences logo

Rosebud Biosciences

NextVivo logo

NextVivo

nextvivo.bio

Unravel Biosciences logo

Unravel Biosciences

unravel.bio

Curi Bio logo

Curi Bio

curibio.com

Pepper Bio logo

Pepper Bio

pepper.bio

Variant Bio logo

Variant Bio

variantbio.com

Harmonic Discovery logo

Harmonic Discovery

Ordaos logo

Ordaos

ordaos.bio

Aracari Biosciences logo

Aracari Biosciences

CN Bio logo

CN Bio

cn-bio.com

Bpgbio logo

Bpgbio

bpgbio.com

TRex Bio logo

TRex Bio

trex.bio

Orionis Biosciences logo

Orionis Biosciences

orionisbio.com

HI-Bio logo

HI-Bio

hibio.com

Transition Bio logo

Transition Bio

transitionbio.com

Parallel Bio - Quick Facts

Who are Parallel Bio's competitors?

Companies similar to Parallel Bio include Rosebud Biosciences, NextVivo, Unravel Biosciences and Curi Bio.

When was Parallel Bio founded?

Parallel Bio was founded in 2021.

Where is Parallel Bio's headquarters located?

Parallel Bio's headquarters is located in Brisbane, CA, US.

When was Parallel Bio's last funding round?

Parallel Bio's most recent funding round was for $21M (USD) in June 2025.

How much has Parallel Bio raised to-date?

As of Jun 12, 2025, Parallel Bio has raised a total of $25.6M (USD).

How many employees does Parallel Bio have?

Parallel Bio has 9 employees as of Feb 10, 2024.

Parallel Bio - Classification

Industry
  • Biotechnology
Ownership
  • Equity
  • Private
  • Venture Capital
Technology
  • AI
  • Biotech
Model
  • Platform
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research